Viewing data from:

VICTRELIS

NDA

BOCEPREVIR | N202258 | MERCK SHARP AND DOHME CORP

1 strength2 unique patents0 unique exclusivities

Patent Timeline

2 unique patents by expiration date

Expiring < 1yr (1)Active (1)Today

2027

Today

Nov. 11, 2027

Mar. 17, 2027

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Gilead Sciences, Inc. v. Merck & Co, Inc. et al 5:2013cv04057 2 patentssofosbuvir	CAND	2013-08-30	Terminated 2016-06-06	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

15 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — 200MG

2 patents0 exclusivities▴

CAPSULE;ORAL | Approved: May 13, 2011

Patent #	Expiration	PED	Drug Substance	Drug Product	Use Code	Delist
7772178	Nov 11, 2027	—	—	Yes		—
8119602	Mar 17, 2027	—	—	—		—